Cephalon Australia Pty. Ltd. is a pharmaceutical company focused on researching, developing, and commercializing innovative medicines to improve the lives of patients with central nervous system disorders, oncology, and other medical conditions. With a commitment to scientific excellence and patient-centered care, Cephalon Australia strives to bring cutting-edge treatments to market to address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#22 in New South Wales

#433 in Australia

New South Wales, Australia

Cephalon Australia Pty. Ltd.

Forward Citations = 18

14 inventors:

Anthony Gerard Doyle (5 out of 32 patents)

Philip Anthony Jennings (5 out of 8 patents)

Linda Gillian Durrant (4 out of 16 patents)

4. Tina Parsons (4 out of 9 patents)

5. Benjamin P Woolven (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cephalon Australia Pty. Ltd.. Retrieved from https://idiyas.com/company/cephalon-australia-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]